ABSTRACT The mitogenic lectins concanavalin A and phytohemagglutinin were found to stimulate pyruvate oxidation in rat mesenteric lymphocytes. Marked cell agglutination accompanied this response. Wheat germ agglutinin, a nonmitogenic lectin, also aggregated lymphocytes but did not cause alteration of pyruvate oxidation. Cell lysates from lectin-treated cells retained their ability to oxidize pyruvate at an elevated rate, indicating that the observed stimulation of pyruvate oxidation was not due to increased transport of labeled pyruvate into the cells. Pyruvate oxidation activity in such lysates was readily sedimented in a mitochondriaenriched cellular (1) (2) (3) (4) (5) (6) (7) (8) (9) (12) (13) (14) .tt These changes include an increase in anabolic reactions such as transport of nutrients, rate ofglycolysis, and synthesis ofprotein, RNA, and DNA (1-4). The detailed molecular mechanisms that occur during lymphocyte activation have not been elucidated. The initial event in the mitogen-induced T-lymphocyte activation involves lectin binding to cell surface glycoproteins (3). This binding occurs rapidly in a manner consistent with a diffusion-controlled process (2) and is followed by patching, capping, and endocytosis of the glycoprotein-lectin complex (5). However, patching and capping alone are not sufficient to stimulate transformation of T lymphocytes, as wheat germ agglutinin causes capping of membrane glycoproteins but is nonmitogenic (6, 7). The intracellular mediation of lymphocyte activation presumably involves one or more metabolic regulators. Several possible regulators have been studied (4, 8) , such as cyclic nucleotides or Ca2+, but none has yet been documented by direct evidence as the primary initial mediator.
ping, and endocytosis of the glycoprotein-lectin complex (5) . However, patching and capping alone are not sufficient to stimulate transformation of T lymphocytes, as wheat germ agglutinin causes capping of membrane glycoproteins but is nonmitogenic (6, 7) . The intracellular mediation of lymphocyte activation presumably involves one or more metabolic regulators. Several possible regulators have been studied (4, 8) , such as cyclic nucleotides or Ca2+, but none has yet been documented by direct evidence as the primary initial mediator.
Recent work in this laboratory has suggested intriguing parallels between the insulin effector system in target tissues sensitive to this hormone and the immunogenic effector system in lymphocytes. For example, the insulin receptor structure has been shown to consist of two types of disulfide-linked subunits in the symmetrical arrangement (,3-S-S-a)-S-S-(a-S-S-, 8) , analogous to the general design of immunoglobulin molecules (9) that serve as receptors for the activation of B lymphocytes (2) . Although the antigen receptor on T lymphocytes has not yet been identified, recent evidence suggests that it is composed of a disulfide-linked dimer that contains idiotypic (variable region) but not isotypic (constant region) determinants.tt Low levels of trypsin both mimic the action of insulin on adipocytes (10) and stimulate lipopolysaccharide-sensitive splenocytes to incorporate [3H]thymidine into DNA (11) and enhance the antibody-forming cell response of hamster lymphocytes to sheep erythrocytes (12) . Furthermore, the insulin-receptor interaction appears to trigger a plasma membrane proteolytic reaction that releases a putative peptide enzyme regulator that modulates the insulin-sensitive enzyme pyruvate dehydrogenase (13) . Several studies have also implicated the activity of an esterase as a key feature ofthe activation ofB lymphocytes by antiimmunoglobulin antiserum (14, 15) . The present studies were designed to explore the hypothesis that the signaling processes for these two systems share common characteristics. It is demonstrated here that lectin action on lymphocytes also leads to rapid activation of pyruvate dehydrogenase and that this activation is inhibited by protease inhibitors.
MATERIALS AND METHODS
Cell Isolation. Mesenteric lymph nodes from male SpragueDawley rats, 150-200 g, were collected in RPMI 1640 tissue culture medium/2% horse serum at 37°C and carefully trimmed to remove connective tissue. The nodes were gently teased between ground glass slides to yield a single-cell suspension. The cells were then suspended in Krebs-Ringer phosphate buffer, pH 7.4/3% bovine serum albumin at 6 x 107/ml. Cell viability was >90% by trypan blue exclusion. All these manipulations were carried out at 37°C. 20 min by the addition of0.2 ml of0.5 M sulfuric acid to the lymphocyte mixture. Phenethylamine (0.2 ml; New England Nuclear) was added immediately to pieces ofWhatman filter paper suspended in plastic wells above the lymphocytes.
Proc. Natd Acad. Sci. USA 78 (1981) 6257 The liberated '4Co2 precipitated on the filter paper was measured in a Packard liquid scintillation counter using Triton X-100 in toluene, 33% (wt/vol) maximally stimulated pyruvate oxidation in lymphocytes by -66% at3.2 ugper3 x 106cells in 150 1.d. The levelofoxidation ofpyruvate in the absence and presence ofphytohemagglutinin (3.2 f&gper3 x lO6cells) was 0.96 ± 0.10and 1.57 ± 0.10 umol of '4C02 produced per 3 x 106 per 20 min, respectively (n = 4). Concanavalin A also increased pyruvate oxidation in lymphocytes in a dose-dependent manner. The level of oxidation of pyruvate in the absence and presence of concanavalin A (20 ,ug per 3 x 106 cells) was 1.39 ± 0.15 and 2.49 ± 0.18 nmol of '4C02 produced per 3 x 106 cells per 20 min, respectively (n = 8). However, wheat germ agglutinin did not significantly increase the oxidation of pyruvate by lymphocytes under the assay conditions used. Addition of 3.6 or 36 ,u&g of wheat germ agglutinin to 3 x 106 cells in the presence of 20 ,mg of concanavalin A decreased only slightly the stimulation of pyruvate oxidation in lymphocytes by concanavalin A alone (data not shown), indicating that the wheat germ agglutinin preparation did not contain a metabolic inhibitor. All three mitogens caused aggregation of lymphocytes but did not affect cell viability during the 20-min assay.
Incubation of lymphocytes with concanavalin A prior to the addition of labeled pyruvate enhanced the stimulation of pyruvate oxidation (Fig. 2) alin A but did not totally abolish the ability ofthe lectin to stimulate pyruvate oxidation in whole cells (data not shown). Cellular viability as determined by trypan blue exclusion was not affected by incubation of lymphocytes with 10 mM p-tosyl-Larginine methyl ester. As shown in Fig. 3B , a-N-benzoyl-L-arginine methyl ester at 2.7 and 13.5 mM also decreased the concanavalin A stimulation of pyruvate oxidation but had no effect on the basal levels of pyruvate oxidation. Two other proteolytic substrates, N-acetyltyrosine ethyl ester and N-acetyl-L-alanyl-L-alanyl-L-alanyl methyl ester, at 2.7 mM did not significantly alter either basal levels or concanavalin A-stimulated levels of pyruvate oxidation in intact lymphocytes (data not shown).
To investigate whether the activation of pyruvate oxidation by lectins survives cell lysis, lymphocytes were treated with concanavalin A and then disrupted. The cell lysates were assayed for their ability to convert [1-'4C] pyruvate to '4Co2. As shown in Fig. 4 W1 of Krebs-Ringer phosphate buffer/3% bovine serium albumin. The incubation was stopped by the addition of 3 ml of ice-cold Krebs-Ringer phosphate buffer, pH 7.4/0.1% bovine serum albumin, and the mixture was centrifuged. Cell pellets were lysed with 100 p1 of 10 mM potassium phosphate buffer, pH 7.4, at 400. Oxidation of pyruvate was measured for 7 min at 370C after the addition of [1-14C]pyruvate and cofactors. The data depict a representative experiment. mM p-tosyl-L-arginine methyl ester to the incubation mixture ofcells and lectin at all concentrations ofconcanavalin A. Again, addition of p-tosyl-L-arginine methyl ester did not alter the basal levels of oxidation in this assay system.
The pyruvate oxidation activity in the cell lysate could be readily sedimented with a cellular fraction rich in mitochondria. In contrast, the specific activity of pyruvate oxidation in lymphocyte supernatant after centrifugation of the cellular lysate at 16,000 X g for 30 min was low in the presence and absence of 2.5 mM magnesium and calcium (0.1-0.3 nmol of "1CO2 evolved per mg per 5 min). However, the particulate fraction demonstrated a higher level of pyruvate oxidation (1.2 nmol of "'CO2 produced per mg per 5 min), which was stimulated to 7.1 nmol Of "'C02 produced per mg per 5 min by the inclusion of 2.5 mM magnesium and calcium in the assay mixture. It is known that mitochondrial pyruvate dehydrogenase is readily stimulated by calcium and magnesium and remains with the mitochondria during isolation (13) . Thus, the pyruvate-oxidizing activity in the cellular lysates probably reflects the activity of pyruvate dehydrogenase, a mitochondrial enzyme.
DISCUSSION
The studies described in this paper show that binding of the mitogenic lectins concanavalin A and phytohemagglutinin to rat mesenteric lymph node cells as demonstrated by cellular agglutination stimulates the oxidation of[l-"4C]pyruvate to "'CO2 in a dose-dependent manner (Fig. 1) (Fig. 4) . The pyruvate oxidation activity in the cell lysate was readily sedimented, as would be expected of a mitochondrial enzyme. Thus, the data suggest that lectin action on lymphocytes leads to rapid activation of pyruvate dehydrogenase.
The possibility that a proteolytic event occurs in response to concanavalin A interaction with plasma membranes and leads to increased pyruvate dehydrogenase activity was investigated by using proteolytic inhibitors. The ability of concanavalin A to stimulate pyruvate oxidation in intact lymphocytes was markedly inhibited by incubation of lymphocytes with the proteolytic substrates p-tosyl-L-arginine methyl ester and a-N-benzoyl-L-arginine methyl ester (Fig. 3) . These two inhibitors displayed no significant effect on the basal rate of pyruvate oxidation. Other proteolytic substrates, N-acetyltyrosine ethyl ether and N-acetyl-L-alanyl-L-alanyl-L-alanyl methyl ester, had no effect on either basal or concanavalin A-stimulated levels of pyruvate oxidation. These data are consistent with the concept that the mediation of mitogen-induced stimulation of pyruvate oxidation involves activation of an arginine-specific protease. The results presented here are indirect, however, and this concept requires rigorous evaluation by further investigation.
Anti-immunoglobulin stimulation of B lymphocytes also appears to be mediated by a mechanism that involves one or more proteolytic events. Hirschorn et aL (17) demonstrated that proteolytic inhibitors decreased phytohemagglutinin stimulation ofDNA, RNA, and protein synthesis in human peripheral blood lymphocytes. Treatment of splenic lymphocytes with anti-immunoglobulin antiserum induced movement of B lymphocytes and required the activation of a serine esterase with arginine specificity (14) . Also, anti-immunoglobulin antiserum treatment of B lymphocytes activated a membrane-bound serine protease, also with arginine specificity, that generated a cytoplasmic factor (15) . This factor was capable of stimulating phosphorylation of nonhistone chromatin proteins in isolated nuclei of untreated cells. It should be noted that, in several other cell types, activation ofa cellular function by specific stimuli can also be depressed by potent inhibitors of serine esterases. Serine protease inhibitors having chymotrypsin specificity depressed the uptake of a chemotactic peptide (18) and inhibited chemotaxis (19) in human peripheral neutrophils. Chymostatin but not other proteolytic inhibitors inhibited phytohemagglutinin-induced aggregation ofhuman peripheral blood lymphocytes (20) .
Our results indicating that mitogenic lectins activate lymphocyte pyruvate dehydrogenase and that this activation is sensitive to antiproteases represent further intriguing parallels between cellular responses accompanying lymphocyte activation and insulin action on its target cells. In both of these models of transmembrane signalling, a number ofcommon cellular responses are elicited synchronously, including activation of membrane transport systems (21) (22) (23) (24) , increases in certain enzyme activities (25) (26) (27) , and changes in the phosphorylation state of specific proteins (28, 29) . It is also striking that lectins mimic the actions of insulin on isolated fat cells (30) , as well as trigger a mitogenic response in lymphocytes (1-4) . The activation of membrane transport systems in adipocytes or muscle by insulin and in lymphocytes by lectins exhibit similar rapid time courses, indicating that they are not secondary to de novo protein synthesis (21, 30) . These similarities between the lymphocyte immunogenic response and the insulin effector system led us to the hypothesis that they share a common mechanism.
Recent experiments by Seals and Jarett (16) have shown that a factor capable of regulating pyruvate dehydrogenase in vitro can be released from isolated adipocyte plasma membrane in response to insulin or concanavalin A. Seals and Czech (13) , further showed that generation of this factor by membranes in the presence of insulin was blocked by antiproteases and protease substrate analogues ofarginine. The bioactivity ofthe factor could also be destroyed by treatment with proteases, suggesting that it is a peptide-like substance released from the membrane in response to insulin-receptor interaction. Preliminary experiments in our laboratory have shown that lymphocyte plasma membranes treated with concanavalin A or phytohemagglutinin release a soluble factor that stimulates pyruvate dehydrogenase activity in either lymphocyte or adipocyte mitochondria (data not shown).
The data presented here are consistent with a model for lymphocyte activation and insulin action whereby the stimulation ofan endogenous membrane protease by ligand binding results in the release of an intracellular mediator from a precursor protein.
